Skip to content

To evaluate the Safety and efficacy of two Unani formulations in the treatment of Gout

Clinical Validation of Unani Pharmacopoeial Formulations - MÄ?jÅ«n-e-SÅ«ranjÄ?n & Habb-e-AzÄ?rÄ?qi in Niqris (Gout)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/03/005610
Enrollment
300
Registered
2015-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified Health Condition 2: null- Niqris (Gout)

Interventions

Intervention1: 1.Majoon-e-SÅ«ranjÄ?n 2.Habb-e-Azaraqi: 1.Majoon SÅ«ranjÄ?n, 5gm.Orally,twice daily with water after meals 2.Habb-e-Azaraqi, Orally, 1 pill twice daily with water after meals Control

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of either sex in the age group of 18-60. • Serum uric acid level: normal or above normal • Patients of gout having any of the following symptoms and signs: ï?§ Joint Pain (especially first metatarsophalangeal (MTP) joint) ï?§ Tenderness ï?§ Swelling ï?§ Redness

Exclusion criteria

Exclusion criteria: • Other diseases involving small & large joints • Pregnant and lactating women • Patients having any systemic diseases such as hypertension, diabetes mellitus, Cardiovascular/Cerebrovascular diseases, hepatic and renal disease, osteomalacia, osteoporosis • Obesity (BMI: >= 30) • Patients on long term medications • Patients taking drugs which increase serum uric acid levels (thiazide diuretics, etc.) and decrease serum calcium levels (furosemide, etc.)

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptoms of Niqris (Gout)Timepoint: Improvement in signs and symptoms of Niqris (Gout)

Secondary

MeasureTime frame
Haematological and biochemical assessment for safety assessmentTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDR PRADEEP KUMAR

Central Council for Research in Unani Medicine (CCRUM),

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026